ICON Public Limited Company
ICLR
주식 순위
#1646
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
주가
$168.23
시가총액
$12.98B
변동 (1일)
-1.15%
변동 (1년)
-9.10%
국가
IE
거래 ICON Public Limited Company (ICLR)
카테고리
Healthcare
ICON Public Limited Company (ICLR)의 EPS
June 2026 기준 EPS TTM: $4.29
ICON Public Limited Company의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $4.29입니다. 2023년 말에는 회사의 EPS가 $7.46였으며, 이는 2022년의 EPS $6.20와 증가입니다.
ICON Public Limited Company의 EPS 기록 (2001 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $4.29 | -55.31% |
| 2024 | $9.60 | 28.69% |
| 2023 | $7.46 | 20.32% |
| 2022 | $6.20 | 171.93% |
| 2021 | $2.28 | -63.75% |
| 2020 | $6.29 | -8.18% |
| 2019 | $6.85 | 14.93% |
| 2018 | $5.96 | 14.62% |
| 2017 | $5.20 | 9.47% |
| 2016 | $4.75 | 16.42% |
| 2015 | $4.08 | 45.71% |
| 2014 | $2.80 | 65.68% |
| 2013 | $1.69 | 83.70% |
| 2012 | $0.92 | 142.11% |
| 2011 | $0.38 | -73.97% |
| 2010 | $1.46 | -9.32% |
| 2009 | $1.61 | 20.15% |
| 2008 | $1.34 | -31.28% |
| 2007 | $1.95 | 44.44% |
| 2006 | $1.35 | 486.96% |
| 2005 | $0.23 | -88.14% |
| 2004 | $1.94 | 25.16% |
| 2003 | $1.55 | 27.05% |
| 2002 | $1.22 | 25.77% |
| 2001 | $0.97 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $18.62 | 334.03% |
US
|
|
| $5.65 | 31.70% |
US
|
|
| $-1.36 | -131.70% |
US
|
|
| - | - |
CN
|
|
| $5.09 | 18.65% |
US
|
